Biological and Pathological Studies of Rosmarinic Acid as an Inhibitor of Hemorrhagic Trimeresurus flavoviridis (habu) Venom by Aung, Hnin Thanda et al.
Toxins 2010, 2, 2478-2489; doi: 10.3390/toxins2102478 
 
toxins
ISSN 2072-6651 
www.mdpi.com/journal/toxins 
Article 
Biological and Pathological Studies of Rosmarinic Acid as an 
Inhibitor of Hemorrhagic Trimeresurus flavoviridis (habu) 
Venom 
Hnin Thanda Aung 
1, Toshiaki Nikai 
1, Yumiko Komori 
1, Tsunemasa Nonogaki 
2,  
Masatake Niwa 
1 and Yoshiaki Takaya 
1,* 
1  Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku, Nagoya, 468-8503, Japan;  
E-Mails: hninthandaaung07@gmail.com (H.T.A.); nikai@meijo-u.ac.jp (T.N.);  
ykomori@meijo-u.ac.jp (Y.K.); masa@meijo-u.ac.jp (M.N.) 
2  College of Pharmacy, Kinjo Gakuin University, 2-1723 Omori, Moriyama, Nagoya, 463-8521, 
Japan; E-Mail: tunenono@kinjo-u.ac.jp 
*  Author to whom correspondence should be addressed; E-Mail: ytakaya@meijo-u.ac.jp;  
Tel.: +81-52-839-2740; Fax: +81-52-839-2740. 
Received: 2 September 2010; in revised form: 5 October 2010 / Accepted: 22 October 2010 / 
Published: 25 October 2010 
 
Abstract: In our previous report, rosmarinic acid (RA) was revealed to be an antidote 
active compound in Argusia argentea (family: Boraginaceae). The plant is locally   
used in Okinawa in Japan as an antidote for poisoning from snake venom,   
Trimeresurus flavoviridis (habu). This article presents mechanistic evidence of RA’s 
neutralization of the hemorrhagic effects of snake venom. Anti-hemorrhagic activity was 
assayed by using several kinds of snake venom. Inhibition against fibrinogen hydrolytic 
and collagen hydrolytic activities of T. flavoviridis venom were examined by SDS-PAGE. 
A histopathological study was done by microscopy after administration of venom in the 
presence or absence of RA. RA was found to markedly neutralize venom-induced 
hemorrhage, fibrinogenolysis, cytotoxicity and digestion of type IV collagen activity. 
Moreover, RA inhibited both hemorrhage and neutrophil infiltrations caused by 
T. flavoviridis venom in pathology sections. These results demonstrate that RA inhibited 
most of the hemorrhage effects of venom. These findings indicate that rosmarinic acid can 
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be expected to provide therapeutic benefits in neutralization of snake venom accompanied 
by heat stability. 
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1. Introduction 
Envenomation resulting from snakebites is an important public health hazard in many regions, 
particularly in tropical and subtropical regions [1–3]. Snake envenomation causes various 
pathophysiological changes such as inflammation, increased body temperature, hemorrhage, necrosis, 
nephrotoxicity, cardiotoxicity, haemostatic changes and ultimately death [4]. Hemorrhage is a common 
symptom associated with local tissue damage in snake poisoning by Viperidae. In severe poisoning, 
hemorrhage can be observed in many internal organs [5,6]. Hemorrhage can occur as a result of 
cytotoxicity of the venom on endothelial cells, and a degradation of the basement membrane of the 
vein due to the venom acting as a metalloproteinase. In many countries, plant extracts have been 
traditionally used in the treatment of snakebite envenomations [7–9], although only a few cases have 
been scientifically validated. The present study aims to examine the venom neutralization potential of 
rosmarinic acid (RA) isolated from a methanolic extract of Argusia argentea [10] and its 
mode of action. 
2. Materials and Methods 
2.1. Materials 
Trimeresurus flavoviridis (habu) venom (Okinawa), Gloydius blomhoffii venom and Bitis arietans 
venom were purchased from Japan Snake Institute, Gunma. Crotalus atrox venom was purchased from 
Sigma-Aldrich. Hemorrhagic toxin b (HTb) from C. atrox venom was prepared by the method reported 
previously [11]. Bilitoxin-2 and Ac1-proteinase were isolated using our methods reported previously 
[12,13] for Agkistrodon bilineatus venom and Deinagkistrodon acutus venom, respectively. 
Hemorrhagic toxin-1 (HT-1) was obtained from B. arietans venom [14]. Human and bovine 
fibrinogens were supplied by Sigma-Aldrich, Tokyo, Japan. Type IV collagen was purchased from 
Nitta Gelatin Inc. Cryo-preserved human umbilical vein endothelial cells (HUVEC), its respective cell 
culture media (HuMedia EB-2), other cell culture supplements, and reagents were obtained from 
Kurabo (Osaka, Japan). The cell counting kit was purchased from Dojindo (Kumamoto, Japan). Other 
chemicals were of analytical grade from commercial sources. All experiments involving the use of 
animals were carried out in compliance with the guidelines for animal experiments of Faculty of 
Pharmacy, Meijo University. 
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2.2. Rosmarinic Acid 
Rosmarinic acid (RA) was isolated and purified from methanolic extract of Argusia argentea as 
reported previously [10]. A voucher sample has been deposited in the Herbarium of the Faculty of 
Pharmacy, Meijo University, Japan. 
2.3. Anti-hemorrhagic Activity Assay 
Anti-hemorrhagic activity was assayed by the method of Bjarnason and Tu [15] using ddY mice  
of 20 g average weight. Two groups of four mice were used for the experiment. All crude venom 
solutions of T. flavoviridis venom, C. atrox venom, G. blomhoffii venom and B. arietans venom, were 
prepared at a concentration of 0.14 mg/mL in saline. Concentrations of purified hemorrhagic toxin 
solutions were as follows: HTb (0.41 mg/mL), bilitoxin-2 (2.75 μg/mL), HT-1 (0.29 mg/mL), and 
Ac1-proteinase (1.04 mg/mL). A test solution was prepared by mixing the venom solution or the toxin 
solution (50 µL) and RA (0.5 mg/mL in 10% DMSO-saline, 50 µL) followed by 10 min incubation 
at 37 °C. These test solutions (100 µL) were injected subcutaneously (s.c.) in the abdomen of mice. 
Similarly, a group of mice which were injected with a venom solution without RA was used as a 
control group, and also a group which was only injected with 10% DMSO-saline (50 μL) served as a 
blank group. Prior to this study, effects of DMSO at several concentrations were investigated, and 
DMSO at less than 10% was found to cause no significant inactivation of venom. After 24 h, mice 
were euthanized by inhalation of chloroform, the skin covering the abdomen was removed and 
hemorrhagic lesions were analyzed as follows. The area of the lesion was estimated by major and 
minor axes measurements, since the shape of the lesions are always amorphous, like an ellipse.  
2.4. Fibrinogen Hydrolytic Activity Assay 
Fibrinogen hydrolytic activity was assayed by the method of Ouyang and Teng [16]. A solution  
of 0.1% human fibrinogen in 50 mM Tris-HCl buffer (pH 7.5) (1 mL) and a venom solution (50 µL  
of 0.21 mg/mL of T. flavoviridis venom or 5.5 µg/mL of bilitoxin-2) were incubated in the presence or 
absence of RA (0.5 mg/mL) at 37 °C. At various time intervals, aliquots of 100 µL of denaturing 
solution (10 mM phosphate buffer, pH 7.2, containing 10 M urea, 4% sodium dodecyl sulfate (SDS), 
and 4% β-mercaptoethanol) were added. This solution was incubated at 37 °C for 6 h and then run  
on 10% polyacrylamide slab gel electrophoresis. Electrophoresis was carried out for 2 h with a current 
of 25 mA per slab gel. Bromophenol blue (BPB) solution was used as an indicator. 
2.5. Collagen Hydrolytic Activity Assay 
Collagen hydrolytic activity was assayed as follows. Sodium hydrogen carbonate (60 µL, pH 12) 
was added to 0.3% type IV collagen (0.9 mL) and adjusted to pH 8. Aliquots of type IV collagen were 
incubated with T. flavoviridis venom (0.21 μg/mL) in the presence or absence of RA (0.5 mg/mL). At 
various time intervals, aliquots of 100 µL of denaturing solution (10 mM phosphate buffer, pH 7.2, Toxins 2010, 2  
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containing 10 M urea, 4% SDS, and 4% β-mercaptoethanol) were added. This solution was boiled  
for 3 min and run on SDS-PAGE using a 7.5% polyacrylamide slab gel electrophoresis. 
2.6. Cytotoxic Action on HUVEC 
The effects of RA and T. flavoviridis venom on cultured human umbilical vein endothelial cells 
(HUVEC) were investigated [17–19]. Frozen HUVEC were cultured and maintained in commercially 
available media, HuMedia-EB2, supplemented with fetal calf serum (2% v/v), hEGF (10 ng/mL), 
hFGF-B (5 ng/mL), hydrocortisone (1 µg/mL), heparin (10 µg/mL), gentamicin (50 µg/mL), and 
amphotericin B (50 ng/mL). At confluency, cells were trypsinized, washed with the same medium and 
then resuspended in growth media. These cells were seeded in 96-multiwell plates (5 × 10
3 cells per 
well in 100 µL medium) and were allowed to attach and reach log phase of growth. Aliquots of venom 
and RA to be assayed were diluted in saline and were sterilized by filtration with cellulose   
acetate 0.22 µm membrane filters. Various concentrations of RA (0.5, 0.25, 0.125, 0.06, 0.03 mg/mL 
in 10% DMSO-saline) in the presence or absence of T. flavoviridis venom (0.14 mg/mL) were added 
to each well in 100 µL medium. The plate was incubated at 37 °C under 5% CO2 atmosphere for 17 h. 
Ten microliters of cell counting kit-8 was added to each well, and the microplate was incubated for 1 h, 
after which cell densities were measured at 450 nm using Bio-RAD Model 550 MicroplateR eader. 
2.7. Histopathological Study 
Histopathological study for RA was performed by intramuscular (i.m.) injection of T. flavoviridis 
venom solution into the medial aspect of the thigh muscle of ddY strain white mice. Histopathological 
study of muscle was conducted in three groups. Group A was injected with the venom (0.21 mg/mL, 
100 µL), while group B was injected with RA (0.5 mg/mL, 100 µL). Group C was injected with a 
mixture of the venom (0.41 mg/mL, 50 µL) and RA (0.25 mg/mL, 50 µL). Test solutions were 
preincubated at 37 °C for 10 min before injection. The mice were killed by chloroform inhalation 24 h 
after injection. Tissue samples were immediately fixed in buffered formate fixative for 24 h at room 
temperature. The tissue was then washed for 4 h in running water, dehydrated in an autotechnicon, and 
stained with hematoxylin and eosin for observation under light microscope. 
2.8. Heat Stability 
RA (0.5 mg/mL) in 10% DMSO-saline was heated at 37 °C, 50 °C and 100 °C for 10 min, 
respectively. Fifty microliters of each heat-treated RA solution was mixed with T. flavoviridis venom 
(0.21 mg/mL, 50 µL) and incubated at 37 °C for 10 min. An aliquot of 0.1% human fibrinogen in 50 mM 
Tris-HCl buffer, pH 7.5 was added to each test tube. The reactions were stopped by adding 100 µL of 
denaturing solution (10 mM phosphate buffer, pH 7.2, containing 10 M urea, 4%  SDS, and 4%   
β-mercaptoethanol). These solutions were incubated at 37 °C for 6 h and then run on 10% 
polyacrylamide slab gel electrophoresis. The venom solution without a sample was also subjected to Toxins 2010, 2  
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SDS-PAGE for comparison. Moreover, by using RA (0.5 mg/mL), which was treated at 100 °C, 
antihemorrhage activity was also examined as mentioned above. 
2.9. Assay for Edema Activity 
Hind-paw edema activity was assayed by the method of Ho et al. [20]. Four ddY strain white mice 
(20–23 g) were individually injected in the right foot pad with Trimeresurus elegans venom (12.5 µg 
in 50 µL of 10% DMSO-saline). An equal volume of 10% DMSO saline was injected into the left 
paws as control. Inhibition assays were performed by preincubated rosmarinic acid (0.5 mg/mL in 10% 
DMSO saline) with toxin for 10 min at 37 °C. The volume of each paw was measured with a slide 
caliper. The degree of paw swelling was expressed as % increase of the initial paw volume. 
3. Results 
3.1. Inhibitory Activity of RA on Crude Snake Venoms and Purified Hemorrhagic Toxins 
When crude venom (T. flavoviridis (habu) venom, C. atrox venom, G. blomhoffii venom, and 
B. arietans venom) or purified toxin, (HTb, bilitoxin-2, HT-1 and Ac1-proteinase) was injected s.c. in 
the abdomen of mice, a distinct hemorrhagic lesion was observed (Figure 1c) [10]. No hemorrhagic 
spots were produced after s.c. injection of crude venom or purified toxin with RA (Figure 1b). 
RA  effectively inhibited the hemorrhagic activities of crude venoms as well as purified 
hemorrhagic toxins. 
Figure 1. Inhibitory activity of RA on T. flavoviridis venom (a) Structure of rosmarinic 
acid, (b) T. flavoviridis venom with RA, (c) T. flavoviridis venom without RA. 
 
3.2. Inhibition of Fibrinogen Hydrolytic Activity 
When human fibrinogen was incubated with T. flavoviridis venom, the Aα band of the fibrinogen 
disappeared on SDS-PAGE, whereas the Bβ chain and γ chain were essentially unaffected (Figure 2a). 
The venom with RA did not reveal any apparent degradation of human fibrinogen (Figure 2b). RA also 
inhibited Aα hydrolysis by bilitoxin-2 (Figure 2c and 2d). Toxins 2010, 2  
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Figure 2. Effect of RA on human fibrinogen hydrolytic activities by T. flavoviridis venom 
and bilitoxin-2. 10% SDS-PAGE of time-dependent digestion of human fibrinogen by 
T. flavoviridis venom and bilitoxin-2 in the presence or absence of RA. (a) T. flavoviridis 
venom without RA; (b)  T. flavoviridis venom with RA; (c) bilitoxin-2 without RA;   
(d) bilitoxin-2 with RA. Molecular weight makers of 97, 66, 43, 30, 20.1, and 14.4 kDa 
were used. 
 
3.3. Inhibition of Venom Cytotoxic Action on HUVEC  
RA alone had no effect on the viability of HUVEC, but it markedly protected HUVEC from the 
toxic effects of T. flavoviridis venom (0.14 mg/mL) at all concentrations of RA tested (0.50, 0.25, 
0.125, 0.06, and 0.03 mg/mL) (Figure 3). The maximum (84.2%) protective effect of RA was 
exhibited with RA at 0.5 mg/mL. 
3.4. Inhibition of Type IV Collagen Hydrolytic Activity 
Type IV collagen was incubated with T. flavoviridis venom for different periods of time. The 
venom completely degraded type IV collagen (104 kDa), especially over 1 h, and degradates with 
smaller molecular weights (43 and 35 kDa) appeared, as shown in Figure 4a. In the presence of RA 
(0.5 mg/mL), type IV collagen was not digested by incubation with the venom (Figure 4b). Toxins 2010, 2  
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Figure 3. Effects of RA against the cytotoxic actions of T. flavoviridis venom on HUVEC. 
 
Figure 4. Effect of RA on type IV collagen hydrolytic activity by T. flavoviridis venom. 
7.5% SDS-PAGE of time-dependent digestion of type IV collagen by T. flavoviridis venom 
in the presence or absence of RA. (a) venom without RA, (b) venom with RA. Molecular 
weight makers of 97, 66, 43, and 30 kDa were used. 
 
3.5. Histological Study of T. flavoviridis Venom and the Effect of RA 
Both hemorrhage and neutrophil infiltrations were observed in a wide area (of the circle) after 
injection of T. flavoviridis venom (0.21 mg/mL) (Figure 5a). The result showed normal musculature 
devoid of hemorrhage and neutrophils in the muscle fibers after injection of RA (0.5 mg/mL) 
(Figure 5b). There was no hemorrhage or neutrolphil infiltration in the muscle fibers after injection of 
a mixture of the venom (0.41 mg/mL) and RA (0.5 mg/mL, or 0.25 mg/mL; Figure 5c). 
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Figure 5. Histological results of thigh muscle after (a) injection of T. flavoviridis venom 
(0.21 mg/mL) alone (b) injection of RA (0.5 mg/mL) alone (normal muscle), (c) injection 
of a mixture of RA (0.25 mg/mL) and the venom (0.41 mg/mL). 
 
3.6. Heat Stability of RA 
RA, which was heated at various temperatures, was incubated with human fibrinogen and 
T. flavoviridis venom. RA inhibited the digestion of Aα chain of human fibrinogen after treatment at 
each temperature (Figure 6). RA (0.5 mg/mL), which was heated at 100 °C for 10 min, also showed 
complete inhibition against T. flavoviridis venom. 
Figure 6. Heat stability study of RA by human fibrinogen digestion by T. flavoviridis 
venom. RA was heated at 37 ºC, 50 ºC, or 100 ºC, then RA (0.5 mg/mL) was mixed with 
human fibrinogen and venom (0.21 mg/mL), and the solution was incubated at 37 °C  
for 10 min. Aliquots were subjected to SDS-PAGE (7.5% gel). 
 
3.7. Inhibition of Venom-Induced Edema 
The edema-forming activity was assayed using four mice. T. elegans venom induced an edema of 
30% in the mouse footpad, at a dose of 12.5 µg. When T. elegans venom was preincubated with RA 
(0.5 mg/mL), the edema-forming was significantly reduced. Toxins 2010, 2  
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4. Discussion 
RA effectively inhibited snake venom induced hemorrhage by crude venoms of T. flavoviridis, 
Crotalus atrox, Gloydius blomhoffii, and B. arietans or purified toxins (HTb, bilitoxin-2, HT-1 and 
Ac1-proteinase) [10]. As shown in Figure 7, envenomation by snakebites often produces persistent 
hemorrhage due to considerable degradation of fibrinogen and other coagulation factors, thus 
preventing clot formation [21]. The pathogenesis of venom-induced hemorrhage involves direct 
damage to endothelial cells in microvessels by hemorrhagic toxins [22,23]. Snake venom 
metalloproteinases (especially snake venom metalloproteinase from T. flavoviridis venom) degrade the 
most important components of the basement membrane, such as laminin, type IV collagen and 
nidogen/entactin [24–26]. In this study, an attempt was made to determine the protective effects of RA 
on digestion of human fibrinogen, digestion of type IV collagen and cytotoxic action on HUVEC 
induced by T. flavoviridis venom. The pure compound showed antifibrinogenolytic activity by 
inhibiting the digestion of the Aα chain of human fibrinogen. RA also effectively inhibited HUVEC 
against the toxic action of T. flavoviridis venom at various concentrations and digestion of type IV 
collagen. Moreover, the pathological study of thigh muscles showed that RA inhibited hemorrhage and 
neutrophil infiltrations. T. flavoviridis venom-induced lethality was significantly antagonized by RA 
(960 µg), whereas the venom is highly lethal to mice with 200 µg. The compound inhibited the 
edema-forming effect of T. elegans venom and lethal action induced by T. flavoviridis venom. The 
aforementioned evidence demonstrates that RA inhibited most of the hemorrhage effects of venom 
(Figure 7). It has been reported that RA isolated from Cordia verbenacea (Boraginaceae) inhibits the 
edema and myotoxic activity induced by crude venom and isolated PLA2s [27]. However, the 
mechanisms of action of PLA2s are quite different from those of metalloproteinases. This is the first 
report of RA that demonstrates the inhibitory mechanism for snake venom induced hemorrhage and 
protection from snakebite envenomation. 
Figure 7. Mechanisms of hemorrhage induction by snake venom, and points of action of 
RA for inhibition of hemorrhage. 
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In this study, the inhibitory activities of rosmarinic acid from Argusia argentea against the action of 
snake venom were investigated. The plant is found on tropical shores of the Pacific and Indian oceans 
and the extract of the leaves are locally used as an antitoxin for snakebites and fish poisoning [28,29]. 
In the Okinawa islands, the leaves of Argusia argentea are the first medical treatment against snake 
venom as well as against jellyfish venom [30]. Hemorrhage is a conspicuous sequela of envenomation 
by Viperidae. Hemorrhage from damage to the vascular endothelium of vital organs causes death [31]. 
These observations confirmed that RA possesses potent snake venom neutralizing properties. 
Furthermore, the heat stability of RA would satisfy a requirement for a first-aid treatment for snakebite. 
Because snakebites often occur outdoors far from medical institutions, it is necessary to distribute a 
drug to distant locations without refrigeration, and the drug must be storable at room temperature. 
Further studies are needed to investigate post-administration of RA, and the effects of different 
methods of administration. After these issues are resolved, RA could become a potent alternative 
antidote compound for snake envenomation. 
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